Viveve Medical found using ticker (VIVE) have now 2 analysts in total covering the stock. The consensus rating is ‘Strong_Buy’. The target price ranges between 22 and 10.75 with the average target price sitting at 16.38. Now with the previous closing price of 3.87 this is indicating there is a potential upside of 323.3%. The day 50 moving average is 3.99 while the 200 day moving average is 5.07. The market cap for the company is $30m. Find out more information at: http://www.viveve.com
Viveve Medical, together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, Canada, and internationally. Viveve Medical was founded in 2005 and is headquartered in Englewood, Colorado.